Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 19,376–19,400 of 27,380 studies, newest first · page 776 of 1096.

July 2012 6

  1. 2012-07-01

    Postoperative delirium: a 76-year-old woman with delirium following surgery

    ✓ Peer-reviewed Prevention and risk JAMA

    Key finding: Delirium (acute confusion) complicates 15% to 50% of major operations in older adults and is associated with other major postoperative complications, prolonged length of stay, poor functional recovery, institutionalization, dementia, and death.

  2. 2012-07-01
  3. 2012-07-01

    [Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial]

    ✓ Peer-reviewed Treatments Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine

    Key finding: The cognitive functions of the patients in the CMG and WMG were improved after treatment. +1 more finding

  4. 2012-07-01

    CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: The results show that the feasibility, treatment adherence, and carer commitment were excellent. +1 more finding

  5. 2012-07-01

    Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

    ✓ Peer-reviewed Treatments Archives of neurology

    Key finding: Antioxidants did not influence CSF biomarkers related to amyloid or tau pathology.

  6. 2012-07-01

    Shapes of the trajectories of 5 major biomarkers of Alzheimer disease

    ✓ Peer-reviewed Genetics Archives of neurology

    Key finding: Biomarker trajectory shapes by MMSE score were complex and were affected by interactions with age and APOE status. +2 more findings

June 2012 19

  1. 2012-06-30

    Exercise counteracts declining hippocampal function in aging and Alzheimer's disease

    ✓ Peer-reviewed Prevention trials Neurobiology of disease

    Key finding: Substantial evidence indicates that physical activity enhances learning and memory for people of all ages, including individuals that suffer from cognitive impairment. +2 more findings

  2. 2012-06-29

    Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition

    ✓ Peer-reviewed Risk factors PloS one

    Key finding: Survival analyses indicated that subjects with the lowest EF scores were more likely to fall sooner and more likely to experience multiple falls during the 66 months of follow-up (p Conclusions/significance These findings demonstrate that among community-living older adults, the risk of future falls was predicted by performance on EF and attention tests conducted 5 years earlier. +4 more findings

  3. 2012-06-28

    Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes

    ✓ Peer-reviewed Brain scans and imaging Neurotoxicity research

    Key finding: The efficacy of melatonin in preventing oxidative damage in either cultured neuronal cells or in the brains of animals treated with various neurotoxic agents, suggests that melatonin has a potential therapeutic value as a neuroprotective drug in treatment of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), stroke, and brain trauma. +2 more findings

  4. 2012-06-28

    Non-stationarity in the "resting brain's" modular architecture

    ✓ Peer-reviewed Brain scans and imaging PloS one

    Key finding: We found that differences in connectivity we and others have previously observed in Alzheimer's disease can be explained by differences in dwell time in DMN sub-network configurations, rather than steady state connectivity magnitude.

  5. 2012-06-28

    Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

    ✓ Peer-reviewed Getting a diagnosis The Lancet. Neurology

    Key finding: For one of the primary analyses, the interpretation of the florbetapir scans (majority interpretation of five nuclear medicine physicians, who classified each scan as amyloid positive or amyloid negative) was compared with amyloid pathology (assessed according to the Consortium to Establish a Registry for Alzheimer's Disease standards, and classed as amyloid positive for moderate or frequent plaques or amyloid negative for no or sparse plaques); correlation of the image analysis results with amyloid burden was tested as a coprimary endpoint. +2 more findings

  6. 2012-06-28

    Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation

    ✓ Peer-reviewed Genetics PLoS genetics

    Key finding: All samples were male, without significant Alzheimer disease pathology and with extensive pathological annotation available. 507 of the 39,122 analyzed expression probes were different between PD and control samples at false discovery rate (FDR) of 5%. +4 more findings

  7. 2012-06-27

    Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer’s disease

    ✓ Peer-reviewed Biomarkers Journal of Anatomy

    Key finding: Here, we analysed the astrocytic cytoskeletal changes within the mPFC of a triple transgenic mouse model of AD (3 × Tg-AD) by measuring the surface area and volume of glial fibrillary acidic protein (GFAP)-positive profiles in relation to the build-up and presence of amyloid-β (Aβ), and compared the results with those found in non-transgenic control animals at different ages. 3 × Tg-AD animals showed clear astroglial cytoskeletal atrophy, which appeared at an early age (3 months; 33% and 47% decrease in GFAP-positive surface area and volume, respectively) and remained throughout the disease progression at 9, 12 and 18 months old (29% and 36%; 37% and 35%; 43% and 37%, respectively). +1 more finding

  8. 2012-06-27

    Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study

    ✓ Peer-reviewed Risk factors Neurology

    Key finding: Smoking, head injury, pesticide exposure, and farming are potential risk factors for idiopathic REM sleep behavior disorder.

  9. 2012-06-26

    Contribution of individual diseases to death in older adults with multiple diseases

    ✓ Peer-reviewed Digital health tools Journal of the American Geriatrics Society

    Key finding: The use of methods that focus on determining a single underlying cause may lead to underestimation of the extent of the contribution of some diseases such as dementia and respiratory disease to death in older adults and overestimation of the contribution of other diseases.

  10. 2012-06-26

    Advances in understanding the molecular basis of frontotemporal dementia

    ✓ Peer-reviewed Disparities Nature reviews. Neurology

    Key finding: Until recently, the underlying cause was known in only a minority of cases that were associated with abnormalities of the tau protein or gene.

  11. 2012-06-26

    Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample

    ✓ Peer-reviewed Brain scans and imaging Brain and behavior

    Key finding: MRI hippocampal volumes were significantly lower in bilateral HS compared to AD (p < 0.001) and in unilateral HS cases compared to cases with intact hippocampi (p < 0.001).

  12. 2012-06-25

    Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data

    ✓ Peer-reviewed Long-term cohort studies BMC neurology

    Key finding: Patients with Mild Cognitive Impairment (MCI) are at high risk of progression to Alzheimer's dementia. +3 more findings

  13. 2012-06-25
  14. 2012-06-23

    Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment

    ✓ Peer-reviewed Digital health tools Neuropharmacology

    Key finding: Significant memory improvement occurred after either intracereboventricular infusion with Compound 44 (100 μg) in a water maze task or systemic administration with Compound 6 (3 mg/kg) in a radial arm maze task.

  15. 2012-06-22

    Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder

    ✓ Peer-reviewed Health systems and care delivery Evidence-Based Mental Health

    Key finding: Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder QUESTION Question: Is atypical antipsychotic use associated with incident diabetes or hyperlipidaemia in older people without schizophrenia or bipolar disorder?

  16. 2012-06-21

    A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial

    ✓ Peer-reviewed Mild cognitive impairment International journal of geriatric psychiatry

    Key finding: Twelve months' treatment with doxycycline or rifampin, alone or in combination, has no beneficial effects on cognition or function in AD. +4 more findings

  17. 2012-06-20

    Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes

    ✓ Peer-reviewed Clinical trials Neurology

    Key finding: The beneficial effect of DBS on motor function was stable and comparable by target over 36 months. +2 more findings

  18. 2012-06-20

    Novel late-onset Alzheimer disease loci variants associate with brain gene expression

    ✓ Peer-reviewed Genetics Neurology

    Key finding: CLU and MS4A4A eSNPs may at least partly explain the LOAD risk association at these loci. +2 more findings

  19. 2012-06-19

    Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data

    ✓ Peer-reviewed Digital health tools BMC health services research

    Key finding: Dementia poses a substantial additional burden to the German social security system, with the long-term care sector being more seriously challenged than the health care sector. +3 more findings

Browse the library by subject, with the full score breakdown →